Eleven Faces of the Toxic CMO: A Veteran's Field Guide

A marketing leader with thirty years in the industry has catalogued eleven types of "toxic CMO" — executives who leave brands weaker than they found them while appearing energetic, progressive and collaborative. "I spent thirty years inside the machine and I can spot a toxic CMO, because admittedly, I have been one at times," the author writes, adding: "it takes one to know one."

The central claim is that these executives are not obviously toxic people. Their flaws arrive disguised as leadership virtues that companies reward. Outside work, the author notes, they can be wonderful people.

What are the eleven types?

The author's typology, drawn from three decades inside marketing departments, includes:

• The Personal Brand Manager. Six weeks in, they decide a sixty-year-old brand has been doing everything wrong. The brand becomes raw material for the CMO's biography: a named transformation project, a conference speech, an awards entry. "Leaving things alone leaves no fingerprints."
• The Action Addict. The activity calendar resembles an air-traffic control screen. When teams complain, the answer is a simplification program, a task force and an urgent prioritization workshop.
• The Growth Junkie. Price promotions and line extensions deliver the next hit while consuming margin and future demand. "Growth velocity passes for growth quality; the detox and the bill both belong to the successor."
• The Fashion Victim. Purpose, DTC, Gen Z, fandom, creators and AI follow one another, each renamed a "growth platform". Being fashionably wrong feels safer than being unfashionably right.
• The Cutting-Edge Dinosaur. This CMO talks brand love and programmatic advertising but has never absorbed Byron Sharp's evidence on penetration, light buyers and mental availability (how readily buyers think of a brand in buying situations). The author compares it to "a doctor prescribing bloodletting through a state-of-the-art app."
• The Insurgent Impersonator. Runs a €2 billion incumbent like a €20 million challenger, with targets of forty-seven people, three of them at the agency.
• The Youth Worshipper. Recognizes two segments: 18–25 and "dying". Existing buyers feel unwelcome.
• The Order Taker. Says yes to every market and sales request; strategy becomes a Christmas tree.
• The Apologetic Marketer. Suspects Sales does the real work, and volunteers marketing budgets for promotions until marketing becomes sales stimulation with a better name.
• The Ivory Tower King. Develops initiatives alone in a silo, then unveils them at a conference choreographed as a coronation.
• The Lucky Genius. Launches as the category accelerates, a competitor stumbles or distribution expands, then claims the campaign caused everything.

The author labels the eleventh type a deliberate "buy X, get one free" addition.

Who produces the toxic CMO?

The essay's sharpest argument shifts blame upward. These figures are not merely recruited, the author writes; they are produced. Companies reward visible action — presentations, milestones, applause — while quiet brand stewardship goes unrewarded.

The CMO sits in a double bind. The CFO wants returns, Sales wants novelty, the CEO wants agility, local markets insist their consumers differ, and boards demand a visionary AI plan. The result is a brief that demands bold yet risk-aware, visionary yet inclusive, locally responsive yet globally consistent leadership. "No wonder the resulting creature sometimes looks slightly deranged. The job description already was."

This does not absolve CMOs, the author argues. Leadership still means resisting unreasonable demands and telling a senior executive an idea is poor, ideally before it acquires a budget.

What should CEOs do?

One CEO, quoted anonymously, captured the tension: "Listen, I have strikes at two plants, retailer pressure on margins, and a budget gap to close this quarter. I'm not going to fight my CMO over a word in a slogan."

The author accepts that executives need not become "Chief Slogan Officers". The point, the author writes, is that committees scrutinize M&A, manufacturing footprints and restructurings for months, and brands deserve comparable shared executive accountability.

Where brands are core assets holding much of a company's value, this is not marketing asking for special treatment, the author concludes — it is corporate governance recognizing what is at stake.